Sa’ad’s Reading List
January 31, 2022 No Comments
Noetic Fund’s Sa’ad Shah is often asked for his favourite books on entheogens and the complex workings of our psyche. We would like to share
Home
OVERVIEW
Noetic Fund
Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system.
About
no•et•ic
“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”
Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.
Mission
Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience.
Commitment
We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations.
Focus
CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.
Investment
Our Portfolio
Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies. Below is a selection of companies we have invested in.
Fund I
Fund II
Corporate VIDEOS
Our Company and Team
Meet The Team
Our Team
Sa'ad Shah
Managing Partner
9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading
9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak
B.A. in Economics and Political Science from Columbia University
Warren Wright
Managing Partner
9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments
12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer
Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group
Sri Teja Mullapudi, Ph.D.
Principal, Fund Investments, Scientific Lead
Helped raise and deploy $60M+ in the psychedelic and neuroscience sectors to improve mental healthcare
Experienced in life sciences investment opportunity analyses from TIAP (MaRS Innovation)
8+ years of research experience with 8 publications in peer-reviewed journals
Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany
M.Tech and B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India
Soccer player with TSV Rödgen, Germany (2014-18), Toronto City FC, Canada (2019-21)
Richard Cheung, B.Sc.Phm., Ph.D., LL.B.
General Counsel
15+ years advising clients ranging from startups to multinational corporations on intellectual property and regulated health products, at firms including Fasken, Ogilvy Renault, and Bereskin & Parr
Licensed pharmacist in the Province of Ontario, with experience in community and hospital pharmacy
LL.B. from Western University
Ph.D. in Pharmaceutical Sciences and B.Sc.Phm. (Pharmacy) from the University of Toronto
Registered Patent Agent and Trademark Agent in Canada
David Schnarr
CCO & Head of Operations
20+ years at Maple Financial Group Inc., serving in a variety of senior finance, compliance and administrative functions
2 years as CFO and CCO at Clearpool Execution Services Canada. Started IIROC-regulated broker-dealer from the beginning. (Company purchased by BMO in 2020.)
Professional designations: CPA, CMA (Canada) and CFA
Yee Tan
Principal, Finance, Operations
25+ years at RBC, covering a spectrum of roles in retail banking, finance, corporate credit, and corporate FX sales.
15+ years of customer focus through structuring, advising, hedging, and executing for a portfolio of corporate clients on cross-border transactions.
B.Comm (Finance) from Dalhousie University. Professional designation: CFA
May Lee
Senior Associate
Cross-functional startup experience across operations, investor relations, marketing, communications and HR
5+ years in the psychedelic-assisted therapeutics and mental health space, including 4 years as the first employee of Numinus, supporting the raise of $60M and Canadian/US expansion
Advisor to Heroic Hearts Project Canada
B.A. in History and International Relations from the University of British Columbia
Victor Mifsud
Head of Real World Evidence
10+ years in the psychedelic/health optimization space and founder of the Vision Optimization Summit
Recently completed a feature-length documentary film called “My Neuroplastic Adventure“
Worked and mentored with renowned national best-selling author and physician Dr. Gabor Maté, Dr. Lara Boyd, and Dr. Norman Doidge
Ryerson University – New Media & Film
Jeffrey Becker, MD
Venture Partner
CSO & Co-Founder of Bexson Biomedical, Inc.
Board-certified in Psychiatry and Integrative & Holistic Medicine
Leader in applied genetics and functional nutrient science in mental health
Ketamine-assisted psychotherapy trainer and opinion leader
Bachelor’s in Biology, Entomology & Religious Mysticism from UC Berkeley. UCLA Medical graduate & psychiatric resident
Marine Mallinson
Venture Advisor
Seasoned tech entrepreneur with two exits, a business data platform with global footprint (GIA) and an Asia wide business expert platform (Fusion)
Board member and investor in mental health companies
Previously, co-founder CEO of a gamified and AI powered social network for cancer patients in China and a video Q&A platform
Ex-investment banker in Tokyo and head of the editorial team of a Japanese publishing house
MSc in Economics and Finance from Sciences Po Paris (Paris Institute of Political Studies) and BA in Japanese Studies from INALCO Paris
Craig Hippern
Advisor
25+ years in the onshore and offshore investment industry
10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company
8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence
CPA,CA (Canada) and CPA(IL) (U.S.A.)
Matthew Baggott, PhD
Venture Partner
CEO of Tactogen
30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development
B.A. in Philosophy and Post-doctoral Fellow at the University of Chicago
Ph.D. in Neuroscience from UC Berkeley
Press
Previous
Next
BLOG PoSTS
Read More »
Subscribe
Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space
CONTACT US
Who to Contact
Do you have a question about our Fund?
Please feel free to get in touch by sending us an email to [email protected].
Do you have a question about your investment?
Please feel free to get in touch by sending us an email to [email protected].
Do you want the Fund to invest in your company?
Please feel free to get in touch by sending us an email to [email protected].
